Trends & Insights
Prepare your medical device quality management system for the FDA QMSR transition effective February 2, 2026. Learn defensive strategies and impact on SMEs.
Learn how to align generative AI with strict GMP standards. This strategic analysis covers EU Annex 22, FDA enforcement, and validatable architecture guidelines.
A deep-dive analysis of the FDA Warning Letter to Respilon Production S.R.O. Learn the strategic path to CGMP compliance and regulatory recovery.
Persimmon Engineering analysis of FDA Form 483 observations at Asteria Health, focusing on process validation, data integrity, and critical contamination risks.